Table 1 Characteristics of the 51 neuro-oncologic radiomics studies with study design of diagnostic, prognostic, or predictive biomarker
Article characteristics | Number of articles* |
|---|---|
Patient number | 153 (standard deviation 82.2; range 32–439) |
Journal type | |
 Clinical journal | 20 (39.2) |
 Imaging journal | 31 (60.8) |
Study inclusion | |
 Gliomas | 46 (90.1) |
  Glioblastoma only | 24 (47.1) |
  Lower grade gliomas only | 15 (29.4) |
  Gliomas (WHO grade I to IV) | 7 (13.7) |
 Other tumors | 5 (9.8) |
Study intent | |
 Differential diagnosis | 6 (11.8) |
 Histopathological grade | 5 (9.8) |
 Molecular/genomic classification | 25†(49.0) |
 Survival | 13† + (25.5) |
 Response to treatment | 3† + (5.9) |
 Others | 1 (2) |
Biomarker | |
 Diagnostic | 36†(70.6) |
 Prognostic | 13† + (25.5) |
 Predictive | 4+ (7.8) |
External validation | |
 Yes | 15 (29.4) |
 No | 36 (70.6) |